Your browser doesn't support javascript.
loading
Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis.
Gupta, Shashank; Cohen, Keira A; Winglee, Kathryn; Maiga, Mamoudou; Diarra, Bassirou; Bishai, William R.
Afiliación
  • Gupta S; Center for Tuberculosis Research, Department of Medicine, JHU, Baltimore, Maryland, USA.
Antimicrob Agents Chemother ; 58(1): 574-6, 2014.
Article en En | MEDLINE | ID: mdl-24126586
ABSTRACT
Drug efflux is an important resistance mechanism in Mycobacterium tuberculosis. We found that verapamil, an efflux inhibitor, profoundly decreases the MIC of bedaquiline and clofazimine to M. tuberculosis by 8- to 16-fold. This exquisite susceptibility was noted among drug-susceptible and drug-resistant clinical isolates. Thus, efflux inhibition is an important sensitizer of bedaquiline and clofazimine, and efflux may emerge as a resistance mechanism to these drugs.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Verapamilo / Diarilquinolinas / Mycobacterium tuberculosis / Antituberculosos Idioma: En Año: 2014 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Verapamilo / Diarilquinolinas / Mycobacterium tuberculosis / Antituberculosos Idioma: En Año: 2014 Tipo del documento: Article